Steven L Basta
CIK 1417397 · President and CEO · last filed 2026-02-12
Steven L Basta is a President and CEO who has filed 40 SEC Form 4 insider transactions across 6 companies since 2008. The most recent filing, for PHAT, was dated Feb 12, 2026. Across all open-market trades the lifetime net is −$81.7K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.90M
6
40
-$81.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PHAT | President and CEO | 373,315 | $10.37 | $3.87M | $0 | 6 | 2026-02-12 |
| VYNE | Director | — | $0.65 | — | $0 | 6 | 2025-12-15 |
| VIVE | Director | 25 | $0.00 | $0 | $0 | 11 | 2023-01-05 |
| VYNE Therapeutics Inc. (MNLO) Delisted | Chief Executive Officer | 536,537 | — | — | $0 | 10 | 2020-08-05 |
| KALV | Director | 1,125 | $27.00 | $30.4K | $0 | 1 | 2016-11-22 |
| BIOFORM MEDICAL INC (BFRM) Delisted | Chief Executive Officer | 0 | — | — | -$81.7K | 5 | 2010-02-19 |
Recent Filings
40 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-12 | PHAT | Mixed | +6,085 | -$80.5K | EDGAR |
| 2026-01-02 | PHAT | Grant (A) | +251,034 | $0 | EDGAR |
| 2025-12-19 | PHAT | Mixed | +30,536 | -$483.9K | EDGAR |
| 2025-12-15 | VYNE | Grant (A) | — | $0 | EDGAR |
| 2025-12-02 | PHAT | Mixed | +41,625 | -$755.6K | EDGAR |
| 2025-09-26 | PHAT | Mixed | +41,625 | -$564.1K | EDGAR |
| 2025-04-03 | PHAT | Grant (A) | — | $0 | EDGAR |
| 2024-12-13 | VYNE | Grant (A) | — | $0 | EDGAR |
| 2024-01-03 | VYNE | Grant (A) | — | $0 | EDGAR |
| 2023-12-15 | VYNE | Grant (A) | — | $0 | EDGAR |